Logo image of RBT.PA

ROBERTET SA (RBT.PA) Stock Fundamental Analysis

EPA:RBT - Euronext Paris - Matif - FR0000039091 - Common Stock - Currency: EUR

855.5  +5.5 (+0.65%)

Fundamental Rating

7

RBT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. RBT gets an excellent profitability rating and is at the same time showing great financial health properties. RBT has a correct valuation and a medium growth rate. These ratings would make RBT suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year RBT was profitable.
In the past year RBT had a positive cash flow from operations.
RBT had positive earnings in each of the past 5 years.
In the past 5 years RBT always reported a positive cash flow from operatings.
RBT.PA Yearly Net Income VS EBIT VS OCF VS FCFRBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

RBT has a Return On Assets of 8.93%. This is amongst the best in the industry. RBT outperforms 92.42% of its industry peers.
RBT has a Return On Equity of 16.32%. This is amongst the best in the industry. RBT outperforms 90.91% of its industry peers.
With an excellent Return On Invested Capital value of 11.47%, RBT belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for RBT is above the industry average of 6.30%.
The last Return On Invested Capital (11.47%) for RBT is above the 3 year average (11.03%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.93%
ROE 16.32%
ROIC 11.47%
ROA(3y)8.62%
ROA(5y)8.51%
ROE(3y)16.89%
ROE(5y)14.89%
ROIC(3y)11.03%
ROIC(5y)10.67%
RBT.PA Yearly ROA, ROE, ROICRBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 11.15%, RBT belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
In the last couple of years the Profit Margin of RBT has grown nicely.
Looking at the Operating Margin, with a value of 15.51%, RBT belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.
RBT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 41.92%, RBT is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
In the last couple of years the Gross Margin of RBT has remained more or less at the same level.
Industry RankSector Rank
OM 15.51%
PM (TTM) 11.15%
GM 41.92%
OM growth 3Y0.15%
OM growth 5Y3.31%
PM growth 3Y-1.95%
PM growth 5Y3.11%
GM growth 3Y0.27%
GM growth 5Y1.28%
RBT.PA Yearly Profit, Operating, Gross MarginsRBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

RBT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, RBT has about the same amount of shares outstanding.
Compared to 5 years ago, RBT has about the same amount of shares outstanding.
RBT has a better debt/assets ratio than last year.
RBT.PA Yearly Shares OutstandingRBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
RBT.PA Yearly Total Debt VS Total AssetsRBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

RBT has an Altman-Z score of 4.79. This indicates that RBT is financially healthy and has little risk of bankruptcy at the moment.
RBT has a Altman-Z score of 4.79. This is amongst the best in the industry. RBT outperforms 87.88% of its industry peers.
RBT has a debt to FCF ratio of 3.94. This is a good value and a sign of high solvency as RBT would need 3.94 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.94, RBT belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
A Debt/Equity ratio of 0.41 indicates that RBT is not too dependend on debt financing.
RBT has a Debt to Equity ratio of 0.41. This is comparable to the rest of the industry: RBT outperforms 53.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 3.94
Altman-Z 4.79
ROIC/WACC1.59
WACC7.2%
RBT.PA Yearly LT Debt VS Equity VS FCFRBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 3.11 indicates that RBT has no problem at all paying its short term obligations.
RBT has a Current ratio of 3.11. This is amongst the best in the industry. RBT outperforms 84.85% of its industry peers.
A Quick Ratio of 1.90 indicates that RBT should not have too much problems paying its short term obligations.
RBT has a Quick ratio of 1.90. This is amongst the best in the industry. RBT outperforms 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 3.11
Quick Ratio 1.9
RBT.PA Yearly Current Assets VS Current LiabilitesRBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

RBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.56%, which is quite impressive.
RBT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.40% yearly.
The Revenue has grown by 11.99% in the past year. This is quite good.
Measured over the past years, RBT shows a small growth in Revenue. The Revenue has been growing by 7.82% on average per year.
EPS 1Y (TTM)20.56%
EPS 3Y11.57%
EPS 5Y13.4%
EPS Q2Q%10.64%
Revenue 1Y (TTM)11.99%
Revenue growth 3Y10.04%
Revenue growth 5Y7.82%
Sales Q2Q%14.02%

3.2 Future

RBT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.13% yearly.
The Revenue is expected to grow by 6.31% on average over the next years.
EPS Next Y5.43%
EPS Next 2Y6.08%
EPS Next 3Y9.06%
EPS Next 5Y7.13%
Revenue Next Year4.63%
Revenue Next 2Y4.73%
Revenue Next 3Y6.81%
Revenue Next 5Y6.31%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
RBT.PA Yearly Revenue VS EstimatesRBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
RBT.PA Yearly EPS VS EstimatesRBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20 40 60

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.87, the valuation of RBT can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of RBT indicates a somewhat cheap valuation: RBT is cheaper than 66.67% of the companies listed in the same industry.
RBT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.91.
Based on the Price/Forward Earnings ratio of 19.12, the valuation of RBT can be described as rather expensive.
RBT's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of RBT to the average of the S&P500 Index (21.85), we can say RBT is valued inline with the index average.
Industry RankSector Rank
PE 19.87
Fwd PE 19.12
RBT.PA Price Earnings VS Forward Price EarningsRBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RBT is on the same level as its industry peers.
RBT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. RBT is cheaper than 65.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.15
EV/EBITDA 12.68
RBT.PA Per share dataRBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RBT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of RBT may justify a higher PE ratio.
PEG (NY)3.66
PEG (5Y)1.48
EPS Next 2Y6.08%
EPS Next 3Y9.06%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.22%, RBT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.12, RBT is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.36, RBT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.22%

5.2 History

On average, the dividend of RBT grows each year by 6.60%, which is quite nice.
Dividend Growth(5Y)6.6%
Div Incr Years2
Div Non Decr Years3
RBT.PA Yearly Dividends per shareRBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

19.74% of the earnings are spent on dividend by RBT. This is a low number and sustainable payout ratio.
The dividend of RBT is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP19.74%
EPS Next 2Y6.08%
EPS Next 3Y9.06%
RBT.PA Yearly Income VS Free CF VS DividendRBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
RBT.PA Dividend Payout.RBT.PA Dividend Payout, showing the Payout Ratio.RBT.PA Dividend Payout.PayoutRetained Earnings

ROBERTET SA

EPA:RBT (5/23/2025, 11:00:00 AM)

855.5

+5.5 (+0.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)07-25 2025-07-25
Inst Owners19.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.86B
Analysts82.86
Price Target1067.6 (24.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.22%
Yearly Dividend7.71
Dividend Growth(5Y)6.6%
DP19.74%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.09%
PT rev (3m)-4.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)1.29%
Valuation
Industry RankSector Rank
PE 19.87
Fwd PE 19.12
P/S 2.3
P/FCF 25.15
P/OCF 16.51
P/B 3.36
P/tB 4.76
EV/EBITDA 12.68
EPS(TTM)43.05
EY5.03%
EPS(NY)44.74
Fwd EY5.23%
FCF(TTM)34.02
FCFY3.98%
OCF(TTM)51.8
OCFY6.06%
SpS372.17
BVpS254.29
TBVpS179.67
PEG (NY)3.66
PEG (5Y)1.48
Profitability
Industry RankSector Rank
ROA 8.93%
ROE 16.32%
ROCE 15.47%
ROIC 11.47%
ROICexc 15.04%
ROICexgc 20.33%
OM 15.51%
PM (TTM) 11.15%
GM 41.92%
FCFM 9.14%
ROA(3y)8.62%
ROA(5y)8.51%
ROE(3y)16.89%
ROE(5y)14.89%
ROIC(3y)11.03%
ROIC(5y)10.67%
ROICexc(3y)14.05%
ROICexc(5y)14.09%
ROICexgc(3y)18.41%
ROICexgc(5y)17.5%
ROCE(3y)14.9%
ROCE(5y)14.47%
ROICexcg growth 3Y3.6%
ROICexcg growth 5Y9.15%
ROICexc growth 3Y-0.95%
ROICexc growth 5Y4.17%
OM growth 3Y0.15%
OM growth 5Y3.31%
PM growth 3Y-1.95%
PM growth 5Y3.11%
GM growth 3Y0.27%
GM growth 5Y1.28%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 3.94
Debt/EBITDA 1.51
Cap/Depr 156.88%
Cap/Sales 4.78%
Interest Coverage 10.89
Cash Conversion 75.01%
Profit Quality 81.96%
Current Ratio 3.11
Quick Ratio 1.9
Altman-Z 4.79
F-Score7
WACC7.2%
ROIC/WACC1.59
Cap/Depr(3y)109.67%
Cap/Depr(5y)99.22%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.32%
Profit Quality(3y)75.59%
Profit Quality(5y)97.4%
High Growth Momentum
Growth
EPS 1Y (TTM)20.56%
EPS 3Y11.57%
EPS 5Y13.4%
EPS Q2Q%10.64%
EPS Next Y5.43%
EPS Next 2Y6.08%
EPS Next 3Y9.06%
EPS Next 5Y7.13%
Revenue 1Y (TTM)11.99%
Revenue growth 3Y10.04%
Revenue growth 5Y7.82%
Sales Q2Q%14.02%
Revenue Next Year4.63%
Revenue Next 2Y4.73%
Revenue Next 3Y6.81%
Revenue Next 5Y6.31%
EBIT growth 1Y12.4%
EBIT growth 3Y10.2%
EBIT growth 5Y11.39%
EBIT Next Year26.44%
EBIT Next 3Y14.11%
EBIT Next 5Y9.92%
FCF growth 1Y-12.61%
FCF growth 3Y4.69%
FCF growth 5Y9.38%
OCF growth 1Y10.41%
OCF growth 3Y9.72%
OCF growth 5Y9.26%